The SLC52A2 gene gives instructions for a protein that carries riboflavin (vitamin B2) into cells, especially in the nervous system. This gene helps your body turn food into energy and support healthy nerves. If both copies of the gene have pathogenic variants, a person can develop riboflavin transporter deficiency, which may lead to hearing loss, muscle weakness, trouble walking, and sometimes breathing or swallowing problems. Early recognition matters because symptoms can improve with riboflavin treatment.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or guide processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
SLC52A2Gene function
What if the gene works
The SLC52A2 gene helps move riboflavin (vitamin B2) into cells. This vitamin supports energy production and the work of nerves and other tissues.
Risk
What if the gene does not work
Variants in the SLC52A2 gene can cause riboflavin transporter deficiency, which affects nerves and may lead to hearing loss, weakness, trouble walking, and breathing problems. Milder and more severe variants can change when symptoms start and how severe they become.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the SLC52A2 gene make high dose riboflavin (vitamin B2) a standard treatment, and many people improve or remain more stable with it. Treatment usually continues long term. Supportive care for breathing, feeding, hearing, or movement may still be needed.
Conditions associated with SLC52A2
Gene function
What if the gene works
Your cells need a steady supply of vitamin B2, also called riboflavin, to turn food into usable energy. The SLC52A2 gene helps move this vitamin from outside the cell to inside, where it can be put to work. Understanding what the SLC52A2 gene does in the body starts with this transport step.
The SLC52A2 gene makes a transporter protein that moves riboflavin, also called vitamin B2, into cells. This gives cells access to a vitamin they cannot make on their own.
Once riboflavin enters the cell, it can be turned into FMN and FAD (helper forms of vitamin B2). These helpers allow many enzymes to carry out routine jobs needed for normal cell activity.
By supplying riboflavin for FMN and FAD, this gene supports how cells release energy from carbohydrates, fats, and proteins. This is especially important in cells with steady, high energy needs, including nerve cells.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC52A2 gene can reduce how well the transporter is folded, reaches the cell surface, or carries riboflavin into cells. This is how SLC52A2 gene variants affect riboflavin transport at the cellular level. Some changes leave partial activity, while more severe variants can make the protein unstable or nearly inactive, and lower remaining activity is often linked to earlier onset and a wider range of features in riboflavin transporter deficiency.
How variants are linked to conditions
Pathogenic variants in the SLC52A2 gene cause riboflavin transporter deficiency type 2, also called Brown-Vialetto-Van Laere syndrome 2. This is one of the main health conditions linked to SLC52A2 gene variants and often begins in childhood with hearing loss, weakness, and trouble swallowing or breathing. Some people also develop nerve problems, vision changes, or problems with balance and movement.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC52A2, the main risk comes from inheritance: a child usually needs to inherit two changed copies, one from each parent, so family history and parents who both carry a change matter most. Once the condition is present, early diagnosis and riboflavin treatment can strongly affect how severe symptoms become.
Inheritance of SLC52A2 variants
Variants in the SLC52A2 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two nonworking copies of the SLC52A2 gene, one from each parent, to have SLC52A2 related disease. Parents who each carry one variant are often unaffected, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variants. Sons and daughters are affected at similar rates.
What does my SLC52A2 result mean for my family?
Changes in the SLC52A2 gene are linked to a condition that usually runs in families in a recessive way. For family members, this often means parents are healthy carriers, brothers and sisters may also be affected or be carriers, and other close relatives could carry the same change without knowing it. A known family result can help relatives understand whether the gene change may also be present in their branch of the family.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the SLC52A2 gene, SLC52A2 genetic testing uses a blood sample, saliva sample, or cheek swab. A laboratory reads the DNA code and checks for changes in the gene. Results may show no variant, a known pathogenic variant, or a variant of uncertain significance (an unclear finding).
When should I consider getting a genetic test?
Consider SLC52A2 testing if you or your child has early hearing loss along with muscle weakness, trouble swallowing, breathing problems, or other nerve symptoms, especially if similar problems run in the family. Testing can help confirm a treatable inherited condition linked to poor vitamin B2 transport.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies with the condition and the kind of variant involved. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug more slowly or more quickly, while others are more or less sensitive to its effects. These differences are common and can influence how well a medicine works or the chance of side effects. Medication response also depends on age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences shape a person’s response to medications. It focuses on the relationship between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC52A2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so any medication concerns are best discussed with your doctor. In people living with SLC52A2-related illness, doctors may still discuss treatment with riboflavin (vitamin B2), because changes in SLC52A2 can affect how this vitamin is moved into cells.
History
SLC52A2 entered medical genetics through work on a rare inherited nerve condition once called Brown Vialetto Van Laere syndrome. Families and communities once noticed patterns that seemed to pass from parent to child. In the early 2010s, researchers linked variants in the SLC52A2 gene to this condition, helping unite earlier clinical observations with a clear genetic cause. Building on this early work, scientists recognized that related genes in the same riboflavin transporter family could cause similar patterns of illness. That discovery mattered because it changed how clinicians classified these conditions and supported earlier diagnosis through genetic testing. Over time, descriptions became more precise as more affected families were identified around the world.